Financial insights of GMED

MyFinsight

For the quarter ending 2026-03-31, GMED made $759,854K in revenue. $123,360K in net income. Net profit margin of 16.23%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net sales	759,854	826,420	769,048	745,342
Cost of sales (exclusive of amortization of intangibles)	234,066	261,107	252,533	248,765
Research and development	36,510	36,163	38,067	39,954
Selling, general and administrative	297,775	318,480	313,597	303,622
Amortization of intangibles	29,526	29,360	29,843	30,189
Acquisition-related costs	6,377	10,826	-2,713	33,156
Restructuring costs	5,212	1,144	358	13,547
Operating income/(loss)	150,388	169,340	137,363	76,109
Interest income/(expense), net	5,434	3,919*	1,455	693
Foreign currency transaction gain/(loss)	-2,113	-7,153	-161	38
Barloss purchase loss	1,118	2,736*	3,800	110,561
Other income/(expense)	2,247	391	1,537	772
Total other income/(expense), net	6,686	-107	6,631	112,064
Income/(loss) before income taxes	157,074	169,233	143,994	188,173
Income tax provision/(benefit)	32,772	28,639	25,028	-14,673
Net income/(loss)	124,302	140,594	118,966	202,846
Unrealized gain/(loss) on marketable securities	-1,160	101	30	2
Foreign currency translation gain/(loss)	218	4,318	658	12,404
Total other comprehensive income/(loss), net of tax	-942	4,419	688	12,406
Comprehensive income/(loss)	123,360	145,013	119,654	215,252

Basic EPS	0.92	1.079	0.88	1.5
Diluted EPS	0.9	1.062	0.88	1.49
Basic Average Shares	135,364,000	134,396,000	134,502,000	135,205,000
Diluted Average Shares	138,191,000	136,557,000	135,394,000	136,499,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.